Source: Siemens HealthcareRadiology reports are consistent with Fleischner Society guidelines (FSG) for management of CT-detected pulmonary nodules in approximately one-third of cases, according to a study published in the July issue of Journal of American College of Radiology.

The FDA has released a proposed rule that most medical devices distributed in the U.S. carry a unique device identifier, or UDI. Congress passed legislation in 2007 directing the FDA to develop regulations establishing a unique device identification system for medical devices.

One Equity Partners, the private investment arm of JP Morgan Chase, will acquire all of the outstanding shares of clinical documentation services provider M*Modal.

Source: Am Jour Roent 2012;199:W27-W34CT colonography (CTC) has received another boost from researchers, as a new study of Medicare-aged patients reinforced CTC as a screening tool for colorectal cancer, according to results published in the July issue of the American Journal of Roentgenology.

An automated lung nodule matching program can improve radiologists efficiency almost two-fold, according to a study published in the July issue of American Journal of Roentgenology.

A new approach to the management of a devastating form of pancreatic cancer could offer hope to patients who were previously told their tumors were inoperable. Using a combination of radiographic restaging, multimodality treatment and advanced surgical techniques, the majority of patients in a recently published study who would have received only palliative, noncurative therapy were deemed to have resectable tumors and saw survival benefits following treatment, according to results appearing in the July issue of the Journal of the American College of Surgeons.

Screening mammography rates among women in their 40s have dropped nearly 6 percent in the U.S. since the U.S. Preventive Services Task Force (USPSTF) recommended against routine mammograms for women in this age group, according to an analysis presented Academy Health Annual Research Meeting, June 24-26, in Orlando, Fla.

Beckman Coulter, the Orange County, Calif.-based biomedical diagnostics products company, has received premarket approval from the FDA for its Prostate Health Index blood test. The phi test is indicated for use in men with a PSA in the range of 4 to 10 ng/mL, who are normally recommended for biopsy by a physician. A multi-center clinical study showed a 31 percent reduction in unnecessary biopsies when utilizing the phi test, according to Beckman Coulter.